Cargando…
Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report
INTRODUCTION: We report here the case of a patient with chronic myeloid leukemia (CML) in the chronic phase who was diagnosed 1 year after receiving a diagnosis of autoimmune hemolytic anemia (AIHA). The objective was to assess if the CML patient progressed from AIHA and explore the underlying facto...
Autores principales: | Li, Xiang, Cai, Sisi, Zhong, Zhaodong, Wang, Hongxiang, Wang, Li, You, Yong, Zhang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478578/ https://www.ncbi.nlm.nih.gov/pubmed/32118733 http://dx.doi.org/10.1097/MD.0000000000019256 |
Ejemplares similares
-
Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022) -
Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions
por: Chen, Chunxia, et al.
Publicado: (2020) -
Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children
por: Chang, Tsung-Yen, et al.
Publicado: (2016) -
Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study
por: Zhou, Ji-cheng, et al.
Publicado: (2020) -
Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)